丽珠医药(01513)8月15日耗资约439.39万元回购11.03万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, intending to repurchase approximately 110,300 A-shares at a cost of about 4.3939 million yuan by August 15, 2025 [1] Company Summary - The company plans to execute a buyback of A-shares, indicating a strategy to enhance shareholder value and potentially signal confidence in its financial health [1] - The total amount allocated for the buyback is approximately 4.3939 million yuan, which reflects the company's commitment to returning capital to shareholders [1] - The specific number of shares targeted for repurchase is 110,300, which may influence the stock's liquidity and market perception [1]